Clinical trials
Recruiting Phase 1 Diabetic Retinopathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 1 |
| MediBeacon | 1 |
| Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. | 1 |
| The Foundation for Orthopaedics and Regenerative Medicine | 1 |
| Therini Bio Pty Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Retinopathy | 5 |
| Macular Degeneration | 2 |
| Eye Diseases | 1 |
| Macular Edema | 1 |
| Optic Atrophy | 1 |
| Optic Nerve Injuries | 1 |
| Retinal Diseases | 1 |
| Retinal Vein Occlusion | 1 |
| Retinitis Pigmentosa | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.